Avai Bio AVAI
OTC AVAI
$0.11 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Avai Bio (AVAI) Receivables - Other (2019 - 2020)

Avai Bio's (AVAI) quarterly Receivables - Other came in at $6365.0 in Q4 2020, down 94.89% year-over-year from $124590.0 in Q1 2020, and down 95.49% quarter-over-quarter from $141210.0 in Q3 2020.

Analysis

Avai Bio (AVAI) Receivables - Other (2019 - 2020) Analysis & Trends

Avai Bio has disclosed Receivables - Other across 2 years of filings, most recently posting $6365.0 for Q4 2020.

  • In Q4 2020, Receivables - Other fell 94.89% year-over-year to $6365.0; the TTM figure through Dec 2020 stood at $6365.0 (down 94.89% YoY), while the FY2020 annual figure was $29574.0, changed N/A from the prior year.
  • Receivables - Other came in at $6365.0 for Q4 2020 at Avai Bio, down from $141210.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $141210.0 in Q3 2020 to a low of $6365.0 in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Baidu 4.12 Bn -18.28 Bn 1.76 Mn
2 Life360 3.37 Bn 3.10 Bn 126.90 Mn
3 Soundhound Ai 2.70 Bn 2.50 Bn 27.93 Mn
4 C3.ai 1.47 Bn 895.72 Mn 11.32 Mn
5 Spectral Capital 455.65 Mn 450.34 Mn 3.28 Mn
6 Spire Global 431.21 Mn 339.54 Mn 6.16 Mn
7 Global AI 147.15 Mn 147.11 Mn 82,446.00
8 Veritone 83.10 Mn 70.68 Mn 15.46 Mn
9 Agassi Sports Entertainment 81.18 Mn 81.11 Mn -
10 Avai Bio 15.58 Mn 15.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 6,365.00
Sep 30, 2020 141,210.00
Jun 30, 2020 93,640.00
Mar 31, 2020 29,574.00
Dec 31, 2019 124,590.00